Winner conducting research on major cause of healthcare-associated infections
Asia
Europe, Middle East, Africa
North America
bioMérieux's Odyssey Tour Brings Education and Training to Healthcare and Quality Assurance Professionals Nationwide
12 May, 2009
High-tech Mobile Laboratory on Cross Country Tour Highlighting Solutions for Laboratory Automation
Clinicians Report Tools to Monitor the Progression of Sepsis Urgently Needed
07 May, 2009
Sepsis progresses so quickly yet there are few clues to indicate treatment is effective.
bioMérieux Takes New Direction to Better Serve Customers and Support the Clinical Laboratory Community
28 April, 2009
Company to Redirect Funding to Drive New Educational Programs and Customer Incentives.
First-Quarter 2009 Business Review: Sales Growth in Line with Objectives
23 April, 2009
bioMérieux, a global leader in the field of in vitro diagnostics, released its quarterly business review through March 31, 2009.
bioMérieux - 2008 Financial Results
16 March, 2009
The Board of Directors of bioMérieux, a global leader in the field of in vitro diagnostics, met on Friday, March 13 to approve the consolidated financial statements for the year ended December 31, 2008. The meeting was chaired by Alain Mérieux and attended by the Statutory Auditors.
bioMérieux Receives AOAC Research Institute Performance Tested MethodsSM Certification for High Performance VIDAS® Easy SLM (Salmonella) Test
24 February, 2009
bioMérieux participating in the AOAC Emergency Response Validation for peanut butter contamination testing. The AOAC Research Institute (RI), a subsidiary of AOAC INTERNATIONAL, granted Performance Tested MethodsSM certification to bioMérieux, a world leader in the field of in vitro diagnostics, for VIDAS® Easy SLM (Salmonella).
bioMérieux - 2008 Business Review
20 January, 2009
bioMérieux, a global leader in the field of in vitro diagnostics, released its business review for fourth-quarter and full-year 2008.
bioMérieux's New TEMPO® Solution Delivers Rapid Results on Direct Enumeration of Yeast and Molds to Improve Food Safety
15 January, 2009
bioMérieux, a world leader in the field of in vitro diagnostics, is enhancing its TEMPO® line for food quality with the launch of one of the most rapid automated solutions for direct enumeration of yeast and mold. TEMPO YM delivers final results in half the time versus most other methods, including the ISO reference method (ISO 21527).
Appointment of Alexandre Mérieux by the bioMérieux Board of Directors
22 December, 2008
At the meeting of the bioMérieux Board of Directors held on December 19, 2008, Alexandre Mérieux was appointed as “Directeur Général Délégué” of the Company. Stéphane Bancel continues to be responsible for all functions in his role as Chief Executive Officer and to chair the bioMérieux Management Committee.